FR2215967A1 - - Google Patents

Info

Publication number
FR2215967A1
FR2215967A1 FR7403419A FR7403419A FR2215967A1 FR 2215967 A1 FR2215967 A1 FR 2215967A1 FR 7403419 A FR7403419 A FR 7403419A FR 7403419 A FR7403419 A FR 7403419A FR 2215967 A1 FR2215967 A1 FR 2215967A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7403419A
Other languages
French (fr)
Other versions
FR2215967B1 (US08063081-20111122-C00042.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH155573A external-priority patent/CH576231A5/de
Priority claimed from CH1273373A external-priority patent/CH576459A5/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2215967A1 publication Critical patent/FR2215967A1/fr
Application granted granted Critical
Publication of FR2215967B1 publication Critical patent/FR2215967B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
FR7403419A 1973-02-02 1974-02-01 Expired FR2215967B1 (US08063081-20111122-C00042.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH155573A CH576231A5 (en) 1973-02-02 1973-02-02 1,2,4,-benztriazine-1,4-di-N-oxide derivs. - used in veterinary medicine against pathogenic micro-organisms or to promote growth
CH1273373A CH576459A5 (en) 1973-09-05 1973-09-05 1,2,4,-benztriazine-1,4-di-N-oxide derivs. - used in veterinary medicine against pathogenic micro-organisms or to promote growth

Publications (2)

Publication Number Publication Date
FR2215967A1 true FR2215967A1 (US08063081-20111122-C00042.png) 1974-08-30
FR2215967B1 FR2215967B1 (US08063081-20111122-C00042.png) 1977-01-28

Family

ID=25687988

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7403419A Expired FR2215967B1 (US08063081-20111122-C00042.png) 1973-02-02 1974-02-01

Country Status (12)

Country Link
US (1) US4160833A (US08063081-20111122-C00042.png)
JP (1) JPS49124235A (US08063081-20111122-C00042.png)
AR (1) AR207145A1 (US08063081-20111122-C00042.png)
BE (1) BE810511A (US08063081-20111122-C00042.png)
CA (1) CA1049014A (US08063081-20111122-C00042.png)
DE (1) DE2404375A1 (US08063081-20111122-C00042.png)
FR (1) FR2215967B1 (US08063081-20111122-C00042.png)
GB (1) GB1465405A (US08063081-20111122-C00042.png)
IE (1) IE38778B1 (US08063081-20111122-C00042.png)
IL (1) IL44058A (US08063081-20111122-C00042.png)
NL (1) NL7401370A (US08063081-20111122-C00042.png)
SU (1) SU589914A3 (US08063081-20111122-C00042.png)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381036A1 (fr) * 1977-02-22 1978-09-15 Ciba Geigy Ag Benzotriazines-1,2,4 et medicaments qui en contiennent
US7851636B2 (en) 2004-01-06 2010-12-14 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US7884210B2 (en) 2005-07-14 2011-02-08 Novo Nordisk A/S Ureido-thiazole glucokinase activators
US7897628B2 (en) 2002-06-27 2011-03-01 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
US7999114B2 (en) 2005-07-08 2011-08-16 Novo Nordisk A/S Dicycloalkylcarbamoyl ureas as glucokinase activators
US8138185B2 (en) 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
US8318778B2 (en) 2007-01-11 2012-11-27 Novo Nordisk A/S Urea glucokinase activators
EP2800744A4 (en) * 2011-12-07 2015-06-03 Sri Internat Inc BENZOTRIAZINE OXIDE AS A MEDICAMENT AGAINST MYCOBACTERIUM TUBERCULOSIS
US11833136B2 (en) 2018-06-12 2023-12-05 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2538179C2 (de) * 1975-08-27 1986-05-28 Bayer Ag, 5090 Leverkusen 3-Alkoxy-benzo-1,2,4-triazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
DE2802488A1 (de) * 1978-01-20 1979-07-26 Bayer Ag 3-azolyl-benzotriazine und -benzotriazin-1-oxide, verfahren zu ihrer herstellung, sowie ihre verwendung zur bekaempfung von pflanzenkrankheiten
NZ194612A (en) * 1979-08-31 1982-12-21 Ici Australia Ltd Benzotriazine derivatives intermediates and herbicidal compositions
US5175287A (en) * 1986-09-25 1992-12-29 S R I International Process for preparing 1,2,4-benzotriazine oxides
DE3790581B4 (de) * 1986-09-25 2004-12-23 Sri International, Menlo Park Verfahren zur selektiven Vernichtung von hypoxischen Tumorzellen
US5616584A (en) 1986-09-25 1997-04-01 Sri International 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
IE62911B1 (en) * 1988-03-18 1995-03-08 Stanford Res Inst Int 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
GR1000941B (el) * 1989-03-17 1993-03-16 Stanford Res Inst Int Μεθοδος παρασκευης οξειδιων 1,2,4,βενζοτριαζινης.
ATE183094T1 (de) * 1989-09-18 1999-08-15 Stanford Res Inst Int 1,2,4-benzotriazinoxide als funkempfindliche und selektive zytotoxische mittel
DE19651415A1 (de) * 1996-12-11 1998-06-18 Henkel Ecolab Gmbh & Co Ohg Verfahren zur Instrumentendesinfektion
AU2002351748B2 (en) * 2001-12-21 2009-07-09 Novo Nordisk A/S Amide derivatives as GK activators
US20050282814A1 (en) * 2002-10-03 2005-12-22 Targegen, Inc. Vasculostatic agents and methods of use thereof
EP1809614B1 (en) * 2004-04-08 2014-05-07 TargeGen, Inc. Benzotriazine inhibitors of kinases
WO2006024034A1 (en) * 2004-08-25 2006-03-02 Targegen, Inc. Heterocyclic compounds and methods of use
MX2007008848A (es) * 2005-06-08 2008-04-16 Targegen Inc Metodos y composiciones para el tratamiento de desordenes oculares.
BR122021011788B1 (pt) 2005-11-01 2022-01-25 Impact Biomedicines, Inc Inibidores de biaril meta pirimidina de cinases, composição farmacêutica e processo para preparar uma composição farmacêutica
US8604042B2 (en) * 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
US8133900B2 (en) * 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
AU2010363329A1 (en) 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
CN115894385A (zh) * 2023-01-09 2023-04-04 中国科学院长春应用化学研究所 替拉扎明衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957779A (en) * 1972-11-15 1976-05-18 Bayer Aktiengesellschaft Benzo-1,2,4-triazines
US3991189A (en) * 1972-11-15 1976-11-09 Bayer Aktiengesellschaft Microbiocidal methods and compositions using substituted 1,2,4-triazine-1,4-di-N-oxide derivatives
SE7501624L (US08063081-20111122-C00042.png) * 1974-03-15 1975-09-16 Ciba Geigy Ag

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381036A1 (fr) * 1977-02-22 1978-09-15 Ciba Geigy Ag Benzotriazines-1,2,4 et medicaments qui en contiennent
US7897628B2 (en) 2002-06-27 2011-03-01 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
US8063081B2 (en) 2002-06-27 2011-11-22 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
US8263634B2 (en) 2004-01-06 2012-09-11 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US7872139B2 (en) 2004-01-06 2011-01-18 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US7851636B2 (en) 2004-01-06 2010-12-14 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
USRE45183E1 (en) 2004-01-06 2014-10-07 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US7999114B2 (en) 2005-07-08 2011-08-16 Novo Nordisk A/S Dicycloalkylcarbamoyl ureas as glucokinase activators
US7884210B2 (en) 2005-07-14 2011-02-08 Novo Nordisk A/S Ureido-thiazole glucokinase activators
US8586614B2 (en) 2005-07-14 2013-11-19 Novo Nordisk A/S Urea glucokinase activators
US8138185B2 (en) 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
US8318778B2 (en) 2007-01-11 2012-11-27 Novo Nordisk A/S Urea glucokinase activators
US8362049B2 (en) 2007-01-11 2013-01-29 Novo Nordisk A/S Urea glucokinase activators
EP2800744A4 (en) * 2011-12-07 2015-06-03 Sri Internat Inc BENZOTRIAZINE OXIDE AS A MEDICAMENT AGAINST MYCOBACTERIUM TUBERCULOSIS
US11833136B2 (en) 2018-06-12 2023-12-05 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
US11974989B2 (en) 2018-06-12 2024-05-07 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Also Published As

Publication number Publication date
US4160833A (en) 1979-07-10
AR207145A1 (es) 1976-09-15
DE2404375A1 (de) 1974-08-08
BE810511A (fr) 1974-08-01
IE38778B1 (en) 1978-05-24
SU589914A3 (ru) 1978-01-25
AU6485674A (en) 1975-07-24
IL44058A0 (en) 1974-05-16
IL44058A (en) 1978-10-31
FR2215967B1 (US08063081-20111122-C00042.png) 1977-01-28
NL7401370A (US08063081-20111122-C00042.png) 1974-08-06
GB1465405A (en) 1977-02-23
JPS49124235A (US08063081-20111122-C00042.png) 1974-11-28
CA1049014A (en) 1979-02-20
IE38778L (en) 1974-08-02

Similar Documents

Publication Publication Date Title
AR201758A1 (US08063081-20111122-C00042.png)
AU476761B2 (US08063081-20111122-C00042.png)
AR201235Q (US08063081-20111122-C00042.png)
AR201231Q (US08063081-20111122-C00042.png)
AU474593B2 (US08063081-20111122-C00042.png)
AU474511B2 (US08063081-20111122-C00042.png)
FR2215967B1 (US08063081-20111122-C00042.png)
AU474838B2 (US08063081-20111122-C00042.png)
AU450229B2 (US08063081-20111122-C00042.png)
AU476714B2 (US08063081-20111122-C00042.png)
AR201229Q (US08063081-20111122-C00042.png)
AU472848B2 (US08063081-20111122-C00042.png)
AU476696B2 (US08063081-20111122-C00042.png)
AR199451A1 (US08063081-20111122-C00042.png)
AU477823B2 (US08063081-20111122-C00042.png)
AU471461B2 (US08063081-20111122-C00042.png)
AR200885A1 (US08063081-20111122-C00042.png)
AR195311A1 (US08063081-20111122-C00042.png)
AR193950A1 (US08063081-20111122-C00042.png)
AR210729A1 (US08063081-20111122-C00042.png)
AR195948A1 (US08063081-20111122-C00042.png)
AR196382A1 (US08063081-20111122-C00042.png)
AR201432A1 (US08063081-20111122-C00042.png)
AU461342B2 (US08063081-20111122-C00042.png)
AR197627A1 (US08063081-20111122-C00042.png)

Legal Events

Date Code Title Description
ST Notification of lapse